The general objective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
26 Jun 2020
Short-term unavailability of iPAAC website on 8 July
On 8 July 2020, the www.ipaac.eu service will not be available due to regular server maintenance works. The outage is planned for the following time slots: 10am (for several minutes) and 11:30am (for ca 30 minutes).
24 Jun 2020
Consensus recommendations for pancreatic cancer care: the Bratislava Statement
Pancreatic cancer is one of the most lethal tumours, and it is the fourth cause of cancer death in Europe. Despite its important public health impact, however, there are no effective treatments or high-visibility research efforts.
26 May 2020
Second iPAAC Local Stakeholder Forum in Slovenia
On Friday, 29 May 2020 the National Institute of Public Health Slovenia (NIJZ) organized the second Local Stakeholder meeting, which was held online via GoToMeeting platform.
29 Apr 2020
IARC, Association of European Cancer Leagues, and Cancer Society of Finland host online conference on the European Code Against Cancer
Scientists from the International Agency for Research on Cancer (IARC), the Association of European Cancer Leagues, and the Cancer Society of Finland hosted an online conference on 28–29 April to discuss cancer prevention and the European Code Against Cancer.